Combination Treatment with Cilostazol and Isosorbide Mononitrate Attenuates Microemboli-mediated Vascular Cognitive Impairment and Improves Imaging and Plasma Biomarkers in Diabetic Rats

Overview

Journal Exp Neurol

Specialty Neurology

Date 2024 Nov 3

PMID 39490626

Authors

Weiguo Li

Alice A Li

Xingju Nie

Joshua Voltin

Lianying He

Eda Karakaya

Jazlyn Edwards

Sarah Jamil

Kareem Abdelsaid

Maria Fatima Falangola

Adviye Ergul

Affiliations

Soon will be listed here.

Abstract

Diabetes is a major risk factor for all types of dementia. The underlying reasons are not fully understood, and preventive therapeutic strategies are lacking. Previously we have shown that diabetic but not control rats developed a progressive cognitive decline in a microemboli (ME) model of vascular contributions to cognitive impairment & dementia (VCID). Given the cerebrovascular dysfunction is a mutual pathological change between diabetes and VCID, we hypothesized that the cognitive impairment in this ME model can be prevented by improving the endothelial function in diabetes. Our treatment paradigm was based on the LACI-2 Trial which assessed the efficacy of isosorbide mononitrate (ISMN) and cilostazol (Cil) treatments in small vessel disease progression. Control and diabetic rats were treated with ISMN/Cil or vehicle for 4 weeks, then injected with cholesterol crystal ME and the behavioral outcomes were monitored. Brain microstructure integrity was assessed by diffusion MRI. Plasma biomarkers were assessed using angiogenesis, neurology and amyloid β 42/40 panels recommended by the MarkVCID consortium. Behavioral deficits and the loss of tissue integrity previously observed in untreated diabetic rats were not noted in the treated animals in this study. Treatment improved tissue perfusion but there were no differences in plasma biomarkers. These results suggest that restoration of endothelial function with ISMN/Cil before ME injection prevented the possible deleterious effects of ME in diabetic rats by improving the endothelial integrity and it is a practical preventive and therapeutic strategy for VCID.

References

Asby D, Boche D, Allan S, Love S, Miners J . Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease. Brain. 2021; 144(6):1869-1883. PMC: 8320299. DOI: 10.1093/brain/awab094. View

Cheng G, Huang C, Deng H, Wang H . Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012; 42(5):484-91. DOI: 10.1111/j.1445-5994.2012.02758.x. View

Chandran R, He L, Nie X, Voltin J, Jamil S, Doueiry C . Magnetic resonance imaging reveals microemboli-mediated pathological changes in brain microstructure in diabetic rats: relevance to vascular cognitive impairment/dementia. Clin Sci (Lond). 2022; 136(21):1555-1570. PMC: 10066787. DOI: 10.1042/CS20220465. View

Kumar A, Kumar A, Jaggi A, Singh N . Efficacy of Cilostazol a selective phosphodiesterase-3 inhibitor in rat model of Streptozotocin diabetes induced vascular dementia. Pharmacol Biochem Behav. 2015; 135:20-30. DOI: 10.1016/j.pbb.2015.05.006. View

Fujita Y, Lin J, Takahashi R, Tomimoto H . Cilostazol alleviates cerebral small-vessel pathology and white-matter lesions in stroke-prone spontaneously hypertensive rats. Brain Res. 2008; 1203:170-6. DOI: 10.1016/j.brainres.2008.01.103. View

Cortes-Canteli M, Iadecola C . Alzheimer's Disease and Vascular Aging: JACC Focus Seminar. J Am Coll Cardiol. 2020; 75(8):942-951. PMC: 8046164. DOI: 10.1016/j.jacc.2019.10.062. View

Lam C, Yoo T, Hiner B, Liu Z, Grutzendler J . Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization. Nature. 2010; 465(7297):478-82. PMC: 2879083. DOI: 10.1038/nature09001. View

Jackson L, Dong G, Althomali W, Sayed M, Eldahshan W, Baban B . Delayed Administration of Angiotensin II Type 2 Receptor (AT2R) Agonist Compound 21 Prevents the Development of Post-stroke Cognitive Impairment in Diabetes Through the Modulation of Microglia Polarization. Transl Stroke Res. 2019; 11(4):762-775. PMC: 7266715. DOI: 10.1007/s12975-019-00752-5. View

Gonzales M, Wiedner C, Wang C, Liu Q, Bis J, Li Z . A population-based meta-analysis of circulating GFAP for cognition and dementia risk. Ann Clin Transl Neurol. 2022; 9(10):1574-1585. PMC: 9539381. DOI: 10.1002/acn3.51652. View

10.

Tabesh A, Jensen J, Ardekani B, Helpern J . Estimation of tensors and tensor-derived measures in diffusional kurtosis imaging. Magn Reson Med. 2011; 65(3):823-36. PMC: 3042509. DOI: 10.1002/mrm.22655. View

11.

Rapp J, Pan X, Neumann M, Hong M, Hollenbeck K, Liu J . Microemboli composed of cholesterol crystals disrupt the blood-brain barrier and reduce cognition. Stroke. 2008; 39(8):2354-61. DOI: 10.1161/STROKEAHA.107.496737. View

12.

Di Marco L, Venneri A, Farkas E, Evans P, Marzo A, Frangi A . Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles. Neurobiol Dis. 2015; 82:593-606. DOI: 10.1016/j.nbd.2015.08.014. View

13.

Schuhmacher S, Oelze M, Bollmann F, Kleinert H, Otto C, Heeren T . Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy. Diabetes. 2011; 60(10):2608-16. PMC: 3178293. DOI: 10.2337/db10-1395. View

14.

Gorelick P, Furie K, Iadecola C, Smith E, Waddy S, Lloyd-Jones D . Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association. Stroke. 2017; 48(10):e284-e303. PMC: 5654545. DOI: 10.1161/STR.0000000000000148. View

15.

Ward R, Valenzuela J, Li W, Dong G, Fagan S, Ergul A . Poststroke cognitive impairment and hippocampal neurovascular remodeling: the impact of diabetes and sex. Am J Physiol Heart Circ Physiol. 2018; 315(5):H1402-H1413. PMC: 6297815. DOI: 10.1152/ajpheart.00390.2018. View

16.

Poggesi A, Pasi M, Pescini F, Pantoni L, Inzitari D . Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review. J Cereb Blood Flow Metab. 2015; 36(1):72-94. PMC: 4758546. DOI: 10.1038/jcbfm.2015.116. View

17.

Iturria-Medina Y, Sotero R, Toussaint P, Mateos-Perez J, Evans A . Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis. Nat Commun. 2016; 7:11934. PMC: 4919512. DOI: 10.1038/ncomms11934. View

18.

Inoue Y, Shue F, Bu G, Kanekiyo T . Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer's disease. Mol Neurodegener. 2023; 18(1):46. PMC: 10334598. DOI: 10.1186/s13024-023-00640-5. View

19.

Reis F, Ponte L, Rocha L, Teixeira-Lemos E, Almeida L, Alcobia T . Curative isosorbide-5-mononitrate treatment, in opposition to the beneficial preventive one, aggravates the prothrombotic and proconstrictor state in cyclosporine-induced hypertensive rats. Clin Exp Pharmacol Physiol. 2005; 32(8):640-8. DOI: 10.1111/j.0305-1870.2005.04244.x. View

20.

Phoenix A, Chandran R, Ergul A . Cerebral Microvascular Senescence and Inflammation in Diabetes. Front Physiol. 2022; 13:864758. PMC: 9098835. DOI: 10.3389/fphys.2022.864758. View